Page 1 of Clinical Trials for Drug Dacarbazine, 453 Total Matches
- 1Active, not recruitingLast Updated: May 2, 2012Condition(s): Metastatic Melanoma
- 2Active, not recruitingLast Updated: May 11, 2012Condition(s): Malignant Melanoma
- 3RecruitingLast Updated: November 22, 2011Condition(s): Adult Lymphocyte Depletion Hodgkin Lymphoma; Adult Lymphocyte Predominant Hodgkin Lymphoma; Adult Mixed Cellularity Hodgkin Lymphoma; Adult Nodular Sclerosis Hodgkin Lymphoma; Stage II Adult Hodgkin Lymphoma; Stage III Adult Hodgkin Lymphoma; Stage IV Adult Hodgkin Lymphoma
- 4Active, not recruitingLast Updated: March 2, 2009Condition(s): Melanoma
- 5RecruitingLast Updated: December 21, 2011Condition(s): Hodgkin Lymphoma
- 6RecruitingLast Updated: December 13, 2011Condition(s): Sarcoma
- 7Active, not recruitingLast Updated: April 30, 2012Condition(s): Melanoma
- 8Active, not recruitingLast Updated: January 4, 2012Condition(s): Disease, Hodgkin
- 9Completed
- 10CompletedLast Updated: March 16, 2011Condition(s): Malignant Melanoma
- 11Active, not recruitingLast Updated: January 27, 2012Condition(s): Sarcoma; Synovial Sarcoma; Leiomyosarcoma; Malignant Peripheral Nerve Sheath Tumor
- 12Active, not recruitingLast Updated: December 15, 2011Condition(s): Solid Tumor; Thyroid Cancer
- 13CompletedLast Updated: July 23, 2008Condition(s): Stage IV Melanoma; Stage III Melanoma; Recurrent Melanoma
- 14RecruitingLast Updated: April 20, 2012Condition(s): Hodgkin Lymphoma
- 15Active, not recruitingDacarbazine With or Without Oblimersen (G3139) in Treating Patients With Advanced Malignant MelanomaLast Updated: April 4, 2009Condition(s): Melanoma (Skin)
- 16CompletedLast Updated: March 11, 2012Condition(s): Advanced Melanoma
- 17RecruitingLast Updated: September 21, 2011Condition(s): Metastatic Melanoma
- 18Active, not recruitingLast Updated: June 23, 2005Condition(s): Melanoma
- 19Active, not recruitingLast Updated: April 4, 2009Condition(s): Melanoma (Skin)
- 20CompletedLast Updated: September 14, 2010Condition(s): Malignant Melanoma
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+Dacarbazine
